目次

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Definition
1.1.1.1 Application Segment
1.1.1.2 Type Segment
1.1.1.3 End Use Segment
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Gvr’s Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List of Secondary Sources
1.11 List of Abbreviations

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Application and Type Snapshot
2.3 End Use Snapshot
2.4 Competitive Landscape Snapshot

Chapter 3 Prostate Cancer Biomarkers Market Variables, Trends, and Scope
3.1 Prostate Cancer Biomarkers Market Lineage Outlook
3.1.1 Parent Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Pipeline Analysis
3.3.1 Screening And Early Detection
3.3.2 Diagnosis And Risk Stratification
3.3.3 Prognosis And Treatment Monitoring
3.3.4 Companion Diagnostics
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Rising prevalence of prostate cancer
3.4.1.2 Advancements in Genomic and Proteomic Technologies
3.4.1.3 Supportive Government and Research Initiatives
3.4.2 Market Restraint Analysis
3.4.2.1 High Cost of Biomarker-Based Tests
3.4.2.2 Uneven Access to Advanced Diagnostic Infrastructure
3.5 Prostate Cancer Biomarkers: Market Analysis Tools
3.5.1 Industry Analysis - Porter’s
3.5.2 Pestle Analysis

Chapter 4 Prostate Cancer Biomarkers Market: Segment Analysis, By Type, 2018 - 2030 (USD Million)
4.1 Prostate Cancer Biomarkers Market: Type Movement Analysis
4.1.1 Genetic Biomarkers
4.1.1.1 Genetic Biomarkers Prostate Cancer Biomarkers Market, 2018 - 2030 (USD Million)
4.1.2 Protein Biomarkers
4.1.2.1 Protein Biomarkers Prostate Cancer Biomarkers Market, 2018 - 2030 (USD Million)
4.1.3 Cell-Based Biomarkers
4.1.3.1 Cell-Based Biomarkers Prostate Cancer Biomarkers Market, 2018 - 2030 (USD Million)
4.1.5 Metabolomic Biomarkers
4.1.5.1 Metabolomic Biomarkers Prostate Cancer Biomarkers Market, 2018 - 2030, USD Million

Chapter 5 Prostate Cancer Biomarkers Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)
5.1 Prostate Cancer Biomarkers Market: Application Movement Analysis
5.1.1 Screening And Early Detection
5.1.1.1 Screening And Early Detection Market, 2018 - 2030 (USD Million)
5.1.2 Diagnosis And Risk Stratification
5.1.2.1 Diagnosis And Risk Stratification Market, 2018 - 2030 (USD Million)
5.1.3 Prognosis And Treatment Monitoring
5.3.1 Prognosis And Treatment Monitoring Market, 2018 - 2030 (USD Million)
5.1.4 Companion Diagnostics
5.1.4.1 Companion Diagnostics Market, 2018 - 2030 (USD Million)

Chapter 6 Prostate Cancer Biomarkers Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)
6.1 Prostate Cancer Biomarkers Market: End Use Movement Analysis
6.1.1 Hospitals And Diagnostic Laboratories
6.1.1.1 Hospitals And Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
6.1.2 Academic And Research Institutes
6.1.2.1 Academic And Research Institutes Market, 2018 - 2030 (USD Million)
6.1.3 Biopharmaceutical Companies
6.1.3.1 Biopharmaceutical Companies Market, 2018 - 2030 (USD Million)

Chapter 7 Prostate Cancer Biomarkers Market: Segment Analysis, By Region, 2018 - 2030 (USD Million)
7.1 Regional Market Snapshot
7.2 North America
7.2.1 North America Prostate Cancer Biomarkers Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. Prostate Cancer Biomarkers Market, 2018 - 2030 (USD Million)
7.2.2.2 Key Country Dynamics
7.2.2.3 Regulatory Framework
7.2.2.4 Reimbursement Scenario
7.2.3 Canada
7.2.3.1 Canada Prostate Cancer Biomarkers Market, 2018 - 2030 (USD Million)
7.2.3.2 Key Country Dynamics
7.2.3.3 Regulatory Framework
7.2.3.4 Reimbursement Scenario
7.2.4 Mexico
7.2.4.1 Mexico Prostate Cancer Biomarkers Market, 2018 - 2030 (USD Million)
7.2.4.2 Key Country Dynamics
7.2.4.3 Regulatory Framework
7.2.4.4 Reimbursement Scenario
7.3 Europe
7.3.1 Europe Prostate Cancer Biomarkers Market, 2018 - 2030 (USD Million)
7.3.2 UK
7.3.2.1 UK Prostate Cancer Biomarkers Market, 2018 - 2030 (USD Million)
7.3.2.2 Key Country Dynamics
7.3.2.3 Regulatory Framework
7.3.2.4 Reimbursement Scenario
7.3.3 Germany
7.3.3.1 Germany Prostate Cancer Biomarkers Market, 2018 - 2030 (USD Million)
7.3.3.2 Key Country Dynamics
7.3.3.3 Regulatory Framework
7.3.3.4 Reimbursement Scenario
7.3.4 Spain
7.3.4.1 Spain Prostate Cancer Biomarkers Market, 2018 - 2030 (USD Million)
7.3.4.2 Key Country Dynamics
7.3.4.3 Regulatory Framework
7.3.4.4 Reimbursement Scenario
7.3.5 France
7.3.5.1 France Prostate Cancer Biomarkers Market, 2018 - 2030 (USD Million)
7.3.5.2 Key Country Dynamics
7.3.5.3 Regulatory Framework
7.3.5.4 Reimbursement Scenario
7.3.6 Italy
7.3.6.1 Italy Prostate Cancer Biomarkers Market, 2018 - 2030 (USD Million)
7.3.6.2 Key Country Dynamics
7.3.6.3 Regulatory Framework
7.3.6.4 Reimbursement Scenario
7.3.7 Denmark
7.3.7.1 Denmark Prostate Cancer Biomarkers Market, 2018 - 2030 (USD Million)
7.3.7.2 Key Country Dynamics
7.3.7.3 Regulatory Framework
7.3.7.4 Reimbursement Scenario
7.3.8 Sweden
7.3.8.1 Sweden Prostate Cancer Biomarkers Market, 2018 - 2030 (USD Million)
7.3.8.2 Key Country Dynamics
7.3.8.3 Regulatory Framework
7.3.8.4 Reimbursement Scenario
7.3.9 Norway
7.3.9.1 Norway Prostate Cancer Biomarkers Market, 2018 - 2030 (USD Million)
7.3.9.2 Key Country Dynamics
7.3.9.3 Regulatory Framework
7.3.9.4 Reimbursement Scenario
7.4 Asia Pacific
7.4.1 Asia-Pacific Prostate Cancer Biomarkers Market, 2018 - 2030 (USD Million)
7.4.2 Japan
7.4.2.1 Japan Prostate Cancer Biomarkers Market, 2018 - 2030 (USD Million)
7.4.2.2 Key Country Dynamics
7.4.2.3 Regulatory Framework
7.4.2.4 Reimbursement Scenario
7.4.3 China
7.4.3.1 China Prostate Cancer Biomarkers Market, 2018 - 2030 (USD Million)
7.4.3.2 Key Country Dynamics
7.4.3.3 Regulatory Framework
7.4.3.4 Reimbursement Scenario
7.4.4 India
7.4.4.1 India Prostate Cancer Biomarkers Market, 2018 - 2030 (USD Million)
7.4.4.2 Key Country Dynamics
7.4.4.3 Regulatory Framework
7.4.4.4 Reimbursement Scenario
7.4.5 South Korea
7.4.5.1 South Korea Prostate Cancer Biomarkers Market, 2018 - 2030 (USD Million)
7.4.5.2 Key Country Dynamics
7.4.5.3 Regulatory Framework
7.4.5.4 Reimbursement Scenario
7.4.6 Thailand
7.4.6.1 Thailand Prostate Cancer Biomarkers Market, 2018 - 2030 (USD Million)
7.4.6.2 Key Country Dynamics
7.4.6.3 Regulatory Framework
7.4.6.4 Reimbursement Scenario
7.4.7 Australia
7.4.7.1 Australia Prostate Cancer Biomarkers Market, 2018 - 2030 (USD Million)
7.4.7.2 Key Country Dynamics
7.4.7.3 Regulatory Framework
7.4.7.4 Reimbursement Scenario
7.5 Latin America
7.5.1 Latin America Prostate Cancer Biomarkers Market, 2018 - 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil Prostate Cancer Biomarkers Market, 2018 - 2030 (USD Million)
7.5.2.2 Key Country Dynamics
7.5.2.3 Regulatory Framework
7.5.2.4 Reimbursement Scenario
7.5.3 Argentina
7.5.3.1 Argentina Prostate Cancer Biomarkers Market, 2018 - 2030 (USD Million)
7.5.3.2 Key Country Dynamics
7.5.3.3 Regulatory Framework
7.5.2.4 Reimbursement Scenario
7.6 MEA
7.6.1 MEA Prostate Cancer Biomarkers Market, 2018 - 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa Prostate Cancer Biomarkers Market, 2018 - 2030 (USD Million)
7.6.2.2 Key Country Dynamics
7.6.2.3 Regulatory Framework
7.6.2.4 Reimbursement Scenario
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia Prostate Cancer Biomarkers Market, 2018 - 2030 (USD Million)
7.6.3.2 Key Country Dynamics
7.6.3.3 Regulatory Framework
7.6.3.4 Reimbursement Scenario
7.6.4 UAE
7.6.4.1 UAE Prostate Cancer Biomarkers Market, 2018 - 2030 (USD Million)
7.6.4.2 Key Country Dynamics
7.6.4.3 Regulatory Framework
7.6.2.4 Reimbursement Scenario
7.6.5 Kuwait
7.6.5.1 Kuwait Prostate Cancer Biomarkers Market, 2018 - 2030 (USD Million)
7.6.5.2 Key Country Dynamics
7.6.5.3 Regulatory Framework
7.6.5.4 Reimbursement Scenario

Chapter 8 Prostate Cancer Biomarkers Market: Competitive Analysis
8.1 Company Categorization
8.2 Strategy Mapping
8.2.1 New product launch
8.2.2 Partnerships
8.2.3 Acquisition
8.2.4 Collaboration
8.2.5 Funding
8.3 Company Market Share Analysis, 2022
8.4 Company Profiles
8.4.1 EXACT SCIENCES CORPORATION
8.4.1.1 Company overview
8.4.1.2 Financial performance
8.4.1.3 Product benchmarking
8.4.1.4 Strategic initiatives
8.4.2 MYRIAD GENETICS, INC.
8.4.2.1 Company overview
8.4.2.2 Financial performance
8.4.2.3 Product benchmarking
8.4.2.4 Strategic initiatives
8.4.3 BIO-TECHNE
8.4.3.1 Company overview
8.4.3.2 Financial performance
8.4.3.3 Product benchmarking
8.4.3.4 Strategic initiatives
8.4.4 EXODX
8.4.4.1 Company overview
8.4.4.2 Product benchmarking
8.4.4.3 Product benchmarking
8.4.4.4 Strategic initiatives
8.4.5 OPKO HEALTH,INC.
8.4.5.1 Company overview
8.4.5.2 Product benchmarking
8.4.5.3 Strategic initiatives
8.4.6 MDXHEALTH
8.4.6.1 Company overview
8.4.6.2 Financial performance
8.4.6.3 Product benchmarking
8.4.6.4 Strategic initiatives
8.4.7 VERACYTE, INC.
8.4.7.1 Company overview
8.4.7.2 Financial performance
8.4.7.3 Product benchmarking
8.4.7.4 Strategic initiatives
8.4.8 BECKMAN COULTER, INC.
8.4.8.1 Company overview
8.4.8.2 Product benchmarking
8.4.9 NUCLEIX
8.4.9.1 Company overview
8.4.9.2 Financial performance
8.4.9.3 Product benchmarking
8.4.9.4 Strategic initiatives
8.4.10 DIACARTA
8.4.10.1 Company overview
8.4.10.2 Product benchmarking
8.4.10.3 Strategic initiatives

List of Tables
Table 1 List of Abbreviation
Table 2 North America Prostate Cancer Biomarkers market, by application, 2018 - 2030 (USD Million)
Table 3 North America Prostate Cancer Biomarkers market, by type, 2018 - 2030 (USD Million)
Table 4 North America Prostate Cancer Biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 5 U.S. Prostate Cancer Biomarkers market, by application, 2018 - 2030 (USD Million)
Table 6 U.S. Prostate Cancer Biomarkers market, by type, 2018 - 2030 (USD Million)
Table 7 U.S. Prostate Cancer Biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 8 Canada Prostate Cancer Biomarkers market, by application, 2018 - 2030 (USD Million)
Table 9 Canada Prostate Cancer Biomarkers market, by type, 2018 - 2030 (USD Million)
Table 10 Canada Prostate Cancer Biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 11 Mexico Prostate Cancer Biomarkers market, by application, 2018 - 2030 (USD Million)
Table 12 Mexico Prostate Cancer Biomarkers market, by type, 2018 - 2030 (USD Million)
Table 13 Mexico Prostate Cancer Biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 11 Europe Prostate Cancer Biomarkers market, by application, 2018 - 2030 (USD Million)
Table 12 Europe Prostate Cancer Biomarkers market, by type, 2018 - 2030 (USD Million)
Table 13 Europe Prostate Cancer Biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 14 U.K. Prostate Cancer Biomarkers market, by application, 2018 - 2030 (USD Million)
Table 15 U.K. Prostate Cancer Biomarkers market, by type, 2018 - 2030 (USD Million)
Table 16 U.K. Prostate Cancer Biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 17 Germany Prostate Cancer Biomarkers market, by application, 2018 - 2030 (USD Million)
Table 18 Germany Prostate Cancer Biomarkers market, by type, 2018 - 2030 (USD Million)
Table 19 Germany Prostate Cancer Biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 20 France Prostate Cancer Biomarkers market, by application, 2018 - 2030 (USD Million)
Table 21 France Prostate Cancer Biomarkers market, by type, 2018 - 2030 (USD Million)
Table 22 France Prostate Cancer Biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 23 Italy Prostate Cancer Biomarkers market, by application, 2018 - 2030 (USD Million)
Table 24 Italy Prostate Cancer Biomarkers market, by type, 2018 - 2030 (USD Million)
Table 25 Italy Prostate Cancer Biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 26 Spain Prostate Cancer Biomarkers market, by application, 2018 - 2030 (USD Million)
Table 27 Spain Prostate Cancer Biomarkers market, by type, 2018 - 2030 (USD Million)
Table 28 Spain Prostate Cancer Biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 29 Denmark Prostate Cancer Biomarkers market, by application, 2018 - 2030 (USD Million)
Table 30 Denmark Prostate Cancer Biomarkers market, by type, 2018 - 2030 (USD Million)
Table 31 Denmark Prostate Cancer Biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 32 Sweden Prostate Cancer Biomarkers market, by application, 2018 - 2030 (USD Million)
Table 33 Sweden Prostate Cancer Biomarkers market, by type, 2018 - 2030 (USD Million)
Table 34 Sweden Prostate Cancer Biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 35 Norway Prostate Cancer Biomarkers market, by application, 2018 - 2030 (USD Million)
Table 36 Norway Prostate Cancer Biomarkers market, by type, 2018 - 2030 (USD Million)
Table 37 Norway Prostate Cancer Biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 38 Asia Pacific Prostate Cancer Biomarkers market, by application, 2018 - 2030 (USD Million)
Table 39 Asia Pacific Prostate Cancer Biomarkers market, by type, 2018 - 2030 (USD Million)
Table 40 Asia Pacific Prostate Cancer Biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 41 Japan Prostate Cancer Biomarkers market, by application, 2018 - 2030 (USD Million)
Table 42 Japan Prostate Cancer Biomarkers market, by type, 2018 - 2030 (USD Million)
Table 43 Japan Prostate Cancer Biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 44 China Prostate Cancer Biomarkers market, by application, 2018 - 2030 (USD Million)
Table 45 China Prostate Cancer Biomarkers market, by type, 2018 - 2030 (USD Million)
Table 46 China Prostate Cancer Biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 47 India Prostate Cancer Biomarkers market, by application, 2018 - 2030 (USD Million)
Table 48 India Prostate Cancer Biomarkers market, by type, 2018 - 2030 (USD Million)
Table 49 India Prostate Cancer Biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 50 South Korea Prostate Cancer Biomarkers market, by application, 2018 - 2030 (USD Million)
Table 51 South Korea Prostate Cancer Biomarkers market, by type, 2018 - 2030 (USD Million)
Table 52 South Korea Prostate Cancer Biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 53 Australia Prostate Cancer Biomarkers market, by application, 2018 - 2030 (USD Million)
Table 54 Australia Prostate Cancer Biomarkers market, by type, 2018 - 2030 (USD Million)
Table 55 Australia Prostate Cancer Biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 56 Thailand Prostate Cancer Biomarkers market, by application, 2018 - 2030 (USD Million)
Table 57 Thailand Prostate Cancer Biomarkers market, by type, 2018 - 2030 (USD Million)
Table 58 Thailand Prostate Cancer Biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 59 Latin America Prostate Cancer Biomarkers market, by application, 2018 - 2030 (USD Million)
Table 60 Latin America Prostate Cancer Biomarkers market, by type, 2018 - 2030 (USD Million)
Table 61 Latin America Prostate Cancer Biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 62 Brazil Prostate Cancer Biomarkers market, by application, 2018 - 2030 (USD Million)
Table 63 Brazil Prostate Cancer Biomarkers market, by type, 2018 - 2030 (USD Million)
Table 64 Brazil Prostate Cancer Biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 68 Argentina Prostate Cancer Biomarkers market, by application, 2018 - 2030 (USD Million)
Table 69 Argentina Prostate Cancer Biomarkers market, by type, 2018 - 2030 (USD Million)
Table 70 Argentina Prostate Cancer Biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 71 MEA Prostate Cancer Biomarkers market, by application, 2018 - 2030 (USD Million)
Table 72 MEA Prostate Cancer Biomarkers market, by type, 2018 - 2030 (USD Million)
Table 73 MEA Prostate Cancer Biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 74 South Africa Prostate Cancer Biomarkers market, by application, 2018 - 2030 (USD Million)
Table 75 South Africa Prostate Cancer Biomarkers market, by type, 2018 - 2030 (USD Million)
Table 76 South Africa Prostate Cancer Biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 77 Saudi Arabia Prostate Cancer Biomarkers market, by application, 2018 - 2030 (USD Million)
Table 78 Saudi Arabia Prostate Cancer Biomarkers market, by type, 2018 - 2030 (USD Million)
Table 79 Saudi Arabia Prostate Cancer Biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 80 UAE Prostate Cancer Biomarkers market, by application, 2018 - 2030 (USD Million)
Table 81 UAE Prostate Cancer Biomarkers market, by type, 2018 - 2030 (USD Million)
Table 82 UAE Prostate Cancer Biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 83 Kuwait Prostate Cancer Biomarkers market, by application, 2018 - 2030 (USD Million)
Table 84 Kuwait Prostate Cancer Biomarkers market, by type, 2018 - 2030 (USD Million)
Table 85 Kuwait Prostate Cancer Biomarkers market, by end use, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Prostate Cancer Biomarkers market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market snapshot
Fig. 10 Segment snapshot (Type and application)
Fig. 11 Segment snapshot (End Use)
Fig. 12 Competitive landscape snapshot
Fig. 13 Biomarkers market value, 2024 (USD Million)
Fig. 14 Prostate Cancer Biomarkers market dynamics
Fig. 15 Prevalence of Screening and Early Detection by age group, 2024
Fig. 16 Prostate Cancer Biomarkers market: PORTER’s analysis
Fig. 17 Prostate Cancer Biomarkers market: PESTLE analysis
Fig. 18 Prostate Cancer Biomarkers market: Type outlook and key takeaways
Fig. 19 Prostate Cancer Biomarkers market: Type movement analysis
Fig. 20 Genetic Biomarkers Prostate Cancer Biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Protein Biomarkers Prostate Cancer Biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Cell-based Biomarkers Prostate Cancer Biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Metabolomic Biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Prostate Cancer Biomarkers market: Application outlook and key takeaways
Fig. 26 Prostate Cancer Biomarkers market: Application movement analysis
Fig. 27 Screening and Early Detection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Diagnosis and Risk Stratification market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Prognosis and Treatment Monitoring market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Companion Diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Prostate Cancer Biomarkers market: End Use outlook and key takeaways
Fig. 33 Prostate Cancer Biomarkers market: End Use movement analysis
Fig. 34 Hospitals and Diagnostic Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Academic and Research Institutes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Biopharmaceutical Companies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Prostate Cancer Biomarkers market revenue, by region, 2022 & 2030, (USD Million)
Fig. 38 Regional marketplace: Key takeaways
Fig. 39 Regional marketplace: Key takeaways
Fig. 40 North America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Key country dynamics
Fig. 42 U.S. Prostate Cancer Biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Target disease prevalence
Fig. 44 Key country dynamics
Fig. 45 Canada Prostate Cancer Biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Target disease prevalence
Fig. 47 Europe Prostate Cancer Biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Key country dynamics
Fig. 49 UK Prostate Cancer Biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Key country dynamics
Fig. 51 Germany Prostate Cancer Biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Target disease prevalence
Fig. 53 Key country dynamics
Fig. 54 France Prostate Cancer Biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Key country dynamics
Fig. 56 Italy Prostate Cancer Biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 Spain Prostate Cancer Biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 Denmark Prostate Cancer Biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Sweden Prostate Cancer Biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 Norway Prostate Cancer Biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 Target disease prevalence
Fig. 66 Rest of Europe market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 Japan Prostate Cancer Biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 Target disease prevalence
Fig. 71 Key country dynamics
Fig. 72 China Prostate Cancer Biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 73 Key country dynamics
Fig. 74 India Prostate Cancer Biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 75 Target disease prevalence
Fig. 76 Key country dynamics
Fig. 77 Australia Prostate Cancer Biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 Key country dynamics
Fig. 79 Thailand Prostate Cancer Biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 Key country dynamics
Fig. 81 South Korea Prostate Cancer Biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 82 Rest of Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 83 Latin America Prostate Cancer Biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 Key country dynamics
Fig. 85 Brazil Prostate Cancer Biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Key country dynamics
Fig. 87 Mexico Prostate Cancer Biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 88 Key country dynamics
Fig. 89 Argentina Prostate Cancer Biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 Rest of Latin America Prostate Cancer Biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 91 MEA Prostate Cancer Biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 92 Key country dynamics
Fig. 93 South Africa Prostate Cancer Biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 94 Target disease prevalence
Fig. 95 Key country dynamics
Fig. 96 Saudi Arabia Prostate Cancer Biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 97 Target disease prevalence
Fig. 98 Key country dynamics
Fig. 99 UAE Prostate Cancer Biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 100 Target disease prevalence
Fig. 101 Key country dynamics
Fig. 102 Kuwait Prostate Cancer Biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 103 Target disease prevalence
Fig. 104 Key payors in Kuwait
Fig. 105 Rest of MEA Prostate Cancer Biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 106 Key company categorization
Fig. 107 Company market positioning
Fig. 108 Company market share analysis, 2022
Fig. 109 Strategic framework